Docgo Inc (DCGO)$0.63
Market Cap: 232.90 MCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Docgo Inc (DCGO).
HEALTHCARE
MEDICAL CARE FACILITIES
DCF ready
Valuation
6.1x
EV/FCF, 16.4% FCF yield
Quality
-136.1%
ROIC, 9.3% FCF margin
Growth
27.9%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.3x current ratio
Superinvestors
1
Top: David Katz (0.0%)
Strengths to research
- Revenue compounded at 27.9% over five years.
- Debt/equity looks manageable at 0.0x.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 6 periods
Quarterly data: 21 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for DCGO.
Grade D
31
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| DCGO Target | Docgo Inc | $232.9M | -0.3x | 6.1x | -136.1% | 27.9% | 9.3% | N/A | N/A | N/A |
| INBX | Inhibrx | $178.5M | -11.2x | -0.4x | -1752.2% | N/A | -9986.5% | N/A | N/A | N/A |
| DMAC | DiaMedica Therapeutics Inc. | $171.4M | N/A | -5.4x | -58.4% | N/A | N/A | N/A | N/A | N/A |
| DNA | Ginkgo Bioworks Holdings Inc. | $402.4M | -1.5x | -1.3x | -0.1% | 17.3% | -105.0% | N/A | N/A | N/A |
| ORIC | ORIC Pharmaceuticals Inc. | $405.2M | -5.7x | -3.2x | -33.7% | N/A | N/A | N/A | N/A | N/A |
| CGEN | Compugen Ltd | $128.1M | 7.4x | 1.2x | 34.4% | 105.2% | 43.1% | 87.3% | -2.8x | N/A |
| LAB | Standard Biotools Inc | $435.8M | -5.1x | -3.8x | -17.7% | -9.2% | -96.9% | 49.9% | N/A | N/A |
| PGEN | Precigen Inc. | $448.7M | -3.1x | -5.7x | -219.7% | -21.3% | -927.6% | N/A | N/A | N/A |
| COYA | Coya Therapeutics Inc | $107.2M | -3.8x | -5.6x | -49.3% | N/A | -135.2% | N/A | N/A | N/A |
Financial Charts
No financial data available for DCGO (annual).
1 superinvestors own DCGO
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| David Katz Matrix Asset Advisors | 100,000 | $63,000 | 0.01% | 0.0% |